DrugDashboards

Sevelamer Carbonate for Oral Suspension

Sevelamer Carbonate for Oral Suspension · SEVELAMER CARBONATE 800 mg/1 · Powder, For Suspension · Oral · Dr. Reddys Laboratories Inc

NDC 43598-0478-90 · 90 PACKET in 1 CARTON / 1 POWDER, FOR SUSPENSION in 1 PACKET · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has fallen 34% in a year, to $0.9713 per unit — and generics that get this cheap tend to get abandoned rather than defended. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.50$5.00$7.50Jan 2021Sep 2026$0.9713
34 price points · per EASource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$851.00
Reported to Texas DSHS · 2026 annual filing · Dr. Reddy's Laboratories, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$100,245
589 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

38Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30
  • price down 32% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for sevelamer carbonate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA210464
TE code
AB
Approval date
Oct 25, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · OngoingJun 26, 2024
    Dr. Reddy's Laboratories, Inc.Labeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on packets

Manufacturers of Sevelamer Carbonate for Oral Suspension (Powder, For Suspension)

LabelerStrengthFirst seenLast seen
Dr. Reddys Laboratories IncSEVELAMER CARBONATE 2400 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddys Laboratories IncSEVELAMER CARBONATE 800 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sevelamer Carbonate for Oral Suspension — NDC 43598-0478-90," retrieved September 3, 2026, https://drugdashboards.com/drug/43598047890.

Free to cite with attribution — see how the data is put together.